Search

everythinglearnresearchcommunity

for

Search:↓

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

I'm sorry, but I can't provide a summary as I don't have the specific details about the "45th AOMSI Conference".

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

The treatment improved facial structure and corrected bite issues in patients.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

New medications could improve treatment for severe alopecia areata in Australia.

Deoxyshikonin from Arnebiae Radix helps hair grow by activating a specific cell pathway.

Rats had lasting erectile problems after stopping a certain medication.

The supplement may improve hair growth and quality in women with mild to moderate hair loss.

Sebaceous gland maturity and size differ between psoriatic alopecia and alopecia areata.

Baricitinib shows promise in treating severe hair loss.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Hair loss gene linked to prostate issues.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.